Jocelyn R James1, JoAnna M Scott2, Jared W Klein3, Sara Jackson3, Christy McKinney4, Matthew Novack4, Lisa Chew3, Joseph O Merrill3. 1. Department of Medicine, Division of General Internal Medicine, Harborview Medical Center, University of Washington School of Medicine, Seattle, WA, USA. jorose@uw.edu. 2. University of Missouri - Kansas City School of Dentistry, Kansas City, MO, USA. 3. Department of Medicine, Division of General Internal Medicine, Harborview Medical Center, University of Washington School of Medicine, Seattle, WA, USA. 4. Tacoma Family Medicine, Multicare, Tacoma, WA, USA.
Abstract
BACKGROUND: Despite known risks of using chronic opioid therapy (COT) for pain, the risks of discontinuation of COT are largely uncharacterized. OBJECTIVE: To evaluate mortality, prescription opioid use, and primary care utilization of patients discontinued from COT, compared with patients maintained on opioids. DESIGN: Retrospective cohort study of patients with chronic pain enrolled in an opioid registry as of May 2010. PARTICIPANTS: Patients with chronic pain enrolled in the opioid registry of a primary care clinic at an urban safety-net hospital in Seattle, WA. MAIN OUTCOMES AND MEASURES: Discontinuation from the opioid registry was the exposure of interest. Pre-specified main outcomes included mortality, prescription and primary care utilization data, and reasons for discontinuation. Data was collected through March 2015. KEY RESULTS: The study cohort comprised 572 patients with a mean age of 54.9 ± 10.1 years. COT was discontinued in 344 patients (60.1%); 254 (73.8%) discontinued patients subsequently filled at least one opioid prescription in Washington State, and 187 (54.4%) continued to visit the clinic. During the study period, 119 (20.8%) registry patients died, and 21 (3.7%) died of definite or possible overdose: 17 (4.9%) discontinued patients died of overdose, whereas 4 (1.75%) retained patients died of overdose. Most patients had at least one provider-initiated reason for COT discontinuation. Discontinuation of COT was associated with a hazard ratio for death of 1.35 (95% CI, 0.92 to 1.98, p = 0.122) and for overdose death of 2.94 (1.01-8.61, p = 0.049), after adjusting for age and race. CONCLUSIONS: In this cohort of patients prescribed COT for chronic pain, mortality was high. Discontinuation of COT did not reduce risk of death and was associated with increased risk of overdose death. Improved clinical strategies, including multimodal pain management and treatment of opioid use disorder, may be needed for this high-risk group.
BACKGROUND: Despite known risks of using chronic opioid therapy (COT) for pain, the risks of discontinuation of COT are largely uncharacterized. OBJECTIVE: To evaluate mortality, prescription opioid use, and primary care utilization of patients discontinued from COT, compared with patients maintained on opioids. DESIGN: Retrospective cohort study of patients with chronic pain enrolled in an opioid registry as of May 2010. PARTICIPANTS: Patients with chronic pain enrolled in the opioid registry of a primary care clinic at an urban safety-net hospital in Seattle, WA. MAIN OUTCOMES AND MEASURES: Discontinuation from the opioid registry was the exposure of interest. Pre-specified main outcomes included mortality, prescription and primary care utilization data, and reasons for discontinuation. Data was collected through March 2015. KEY RESULTS: The study cohort comprised 572 patients with a mean age of 54.9 ± 10.1 years. COT was discontinued in 344 patients (60.1%); 254 (73.8%) discontinued patients subsequently filled at least one opioid prescription in Washington State, and 187 (54.4%) continued to visit the clinic. During the study period, 119 (20.8%) registry patients died, and 21 (3.7%) died of definite or possible overdose: 17 (4.9%) discontinued patients died of overdose, whereas 4 (1.75%) retained patients died of overdose. Most patients had at least one provider-initiated reason for COT discontinuation. Discontinuation of COT was associated with a hazard ratio for death of 1.35 (95% CI, 0.92 to 1.98, p = 0.122) and for overdose death of 2.94 (1.01-8.61, p = 0.049), after adjusting for age and race. CONCLUSIONS: In this cohort of patients prescribed COT for chronic pain, mortality was high. Discontinuation of COT did not reduce risk of death and was associated with increased risk of overdose death. Improved clinical strategies, including multimodal pain management and treatment of opioid use disorder, may be needed for this high-risk group.
Authors: Beth D Darnall; David Juurlink; Robert D Kerns; Sean Mackey; Brent Van Dorsten; Keith Humphreys; Julio A Gonzalez-Sotomayor; Andrea Furlan; Adam J Gordon; Debra B Gordon; Diane E Hoffman; Joel Katz; Stefan G Kertesz; Sally Satel; Richard A Lawhern; Kate M Nicholson; Rosemary C Polomano; Owen D Williamson; Heath McAnally; Ming-Chih Kao; Stephan Schug; Robert Twillman; Terri A Lewis; Richard L Stieg; Kate Lorig; Theresa Mallick-Searle; Robert W West; Sarah Gray; Steven R Ariens; Jennifer Sharpe Potter; Penney Cowan; Chad D Kollas; Danial Laird; Barby Ingle; J Julian Grove; Marian Wilson; Kashelle Lockman; Fiona Hodson; Carol S Palackdharry; Roger B Fillingim; Jeffrey Fudin; Jennifer Barnhouse; Ajay Manhapra; Steven R Henson; Bruce Singer; Marie Ljosenvoor; Marlisa Griffith; Jason N Doctor; Kimeron Hardin; Cathleen London; Jon Mankowski; Andrea Anderson; Linda Ellsworth; Lisa Davis Budzinski; Becky Brandt; Greg Hartley; Debbie Nickels Heck; Mark J Zobrosky; Celeste Cheek; Megan Wilson; Cynthia E Laux; Geralyn Datz; Justin Dunaway; Eileen Schonfeld; Melissa Cady; Thérèse LeDantec-Boswell; Meredith Craigie; John Sturgeon; Pamela Flood; Melita Giummarra; Jessica Whelan; Beverly E Thorn; Richard L Martin; Michael E Schatman; Maurice D Gregory; Joshua Kirz; Patti Robinson; James G Marx; Jessica R Stewart; Phillip S Keck; Scott E Hadland; Jennifer L Murphy; Mark A Lumley; Kathleen S Brown; Michael S Leong; Mechele Fillman; James W Broatch; Aaron Perez; Kristine Watford; Kari Kruska; Dokyoung Sophia You; Stacy Ogbeide; Amy Kukucka; Susan Lawson; James B Ray; T Wade Martin; James B Lakehomer; Anne Burke; Robert I Cohen; Peter Grinspoon; Marc S Rubenstein; Stephani Sutherland; Kristie Walters; Travis Lovejoy Journal: Pain Med Date: 2019-03-01 Impact factor: 3.750
Authors: Mark J Edlund; Bradley C Martin; Joan E Russo; Andrea DeVries; Jennifer B Braden; Mark D Sullivan Journal: Clin J Pain Date: 2014-07 Impact factor: 3.442
Authors: Ajay Manhapra; Mark D Sullivan; Jane C Ballantyne; R Ross MacLean; William C Becker Journal: J Gen Intern Med Date: 2020-11-06 Impact factor: 5.128
Authors: Daniel M Walker; Janet E Childerhose; Sadie Chen; Nicolette Coovert; Rebecca D Jackson; Natasha Kurien; Ann Scheck McAlearney; Jaclyn Volney; Daniel P Alford; Julie Bosak; Douglas R Oyler; Laura K Stinson; Melika Behrooz; Mia-Cara Christopher; Mari-Lynn Drainoni Journal: Drug Alcohol Depend Date: 2022-02-02 Impact factor: 4.492
Authors: Daniel M Hartung; Kirbee A Johnston; Sara Hallvik; Gillian Leichtling; Jonah Geddes; Christi Hildebran; Shellie Keast; Brian Chan; P Todd Korthuis Journal: J Gen Intern Med Date: 2020-09-15 Impact factor: 5.128
Authors: Michele Buonora; Hector R Perez; Jordan Stumph; Robert Allen; Shadi Nahvi; Chinazo O Cunningham; Jessica S Merlin; Joanna L Starrels Journal: Pain Med Date: 2020-10-01 Impact factor: 3.750
Authors: K S Gordon; A Manhapra; S Crystal; J Dziura; E J Edelman; M Skanderson; R D Kerns; A C Justice; J Tate; W C Becker Journal: Drug Alcohol Depend Date: 2020-09-16 Impact factor: 4.492